UK markets open in 1 hour 41 minutes

PCI Biotech Holding ASA (0JGL.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
2.8200+0.2300 (+8.88%)
At close: 09:05AM BST
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.62
52-week change 3N/A
S&P500 52-week change 324.49%
52-week high 30.0000
52-week low 30.0000
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 829.86M
% held by insiders 123.95%
% held by institutions 18.57%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-370.62%

Management effectiveness

Return on assets (ttm)-25.85%
Return on equity (ttm)-42.13%

Income statement

Revenue (ttm)2.99M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)8.40%
Gross profit (ttm)N/A
EBITDA -21.87M
Net income avi to common (ttm)-20.32M
Diluted EPS (ttm)-2.3480
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)41.18M
Total cash per share (mrq)1.1
Total debt (mrq)319k
Total debt/equity (mrq)0.82%
Current ratio (mrq)8.80
Book value per share (mrq)1.05

Cash flow statement

Operating cash flow (ttm)-15.07M
Levered free cash flow (ttm)-8.74M